ZVRA today
$11.16-$0.69 (-5.82%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourBearish
1 hourSymmetric Triangle
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $15.04
Key levels
Resistance$12.20
Resistance$11.46
Support$10.55
Support$9.95
Latest news & SEC filings
EarningsZevra Therapeutics holds Q3 2026 earnings call
EarningsZevra Therapeutics quarterly profit and revenue top Wall Street targets
EarningsZevra Therapeutics Posts Q3 2026 Financials
SEC FilingZevra Therapeutics, Inc. filed a report on a major company event (Form 8-K)
All ZVRA news →About Zevra Therapeutics
Zevra Therapeutics is a commercial-stage biopharmaceutical company that develops and sells treatments for rare diseases. Its marketed medicines include MIPLYFFA, an oral therapy for a rare neurodegenerative cholesterol storage disorder, and OLPRUVA, used in certain inherited urea cycle conditions; both are sold in the United States. The company is also developing celiprolol for a connective tissue disorder affecting blood vessels and serdexmethylphenidate candidates for sleep-related conditions, and it earns royalties from AZSTARYS for ADHD. It serves patients and physicians in the U.S. and Europe.
Based on the company's 10-K filed Mar 9, 2026.
Nasdaq · Healthcare
ZEVRA THERAPEUTICS, INC. (ZVRA)
What Is the Price Target for ZVRA?
SEPT Low Target
$20.00
SEPT Mid Target
$26.00
SEPT High Target
$35.00
Analyst Consensus
$26.00
Is ZVRA a Buy or Sell Right Now?
Thesis
- •Revenue growing 350.9% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ZVRA.
Start Free Trial →Is ZVRA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$22.59
56
Moat Score
NARROW
5/9
Piotroski Score
1.5
Altman Z-Score
What Is Smart Money Doing with ZVRA?
Insider Signal
SELLING
0 buys / 9 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ZVRA Growth Story
Revenue YoY
350.9%
3yr Revenue CAGR
118.8%
EPS Growth YoY
159.21%
FCF Growth YoY
96.5%
Revenue Trend
ACCELERATING
Dark Pool Trades for ZVRA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ZVRA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:04 | $11.16 | 2,095 | $$23K | BUY |
| 21:00:04 | $11.16 | 13,898 | $$155K | BUY |
| 20:54:42 | $11.17 | 6,500 | $$73K | SELL |
| 20:54:42 | $11.17 | 2,600 | $$29K | SELL |
| 20:48:14 | $11.21 | 1,800 | $$20K | BUY |
5 dark pool trades shown · $$300K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ZVRA
PREVIEWSEPT Investing provides real-time options flow tracking for ZVRA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $10 | Dec 17 | 400 | $$1930 | 10 | SWEEP |
| PUT | $10 | Dec 17 | 400 | $$1930 | 10 | SWEEP |
| PUT | $10 | Jan 21 | 435 | $$1980 | 10 | SWEEP |
| PUT | $10 | Jan 21 | 435 | $$1980 | 10 | SWEEP |
| PUT | $10 | Jan 21 | 435 | $$1980 | 10 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for ZEVRA THERAPEUTICS, INC. (ZVRA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ZVRA — frequently asked questions
What is ZVRA stock price today?
ZEVRA THERAPEUTICS, INC. (ZVRA) is at $11.16, down 5.82% (-$0.69) at the Nov 12, 2026 close.
Why is ZVRA stock moving today?
Latest ZVRA news — Nov 3, 2026: Zevra Therapeutics holds Q3 2026 earnings call · Nov 3, 2026: Zevra Therapeutics quarterly profit and revenue top Wall Street targets
What is the ZVRA price target?
The average analyst price target for ZVRA is $26.00, ranging from $20 to $35, based on 7 analysts.
What do analysts rate ZVRA?
Analyst ratings for ZVRA: 0 Buy, 14 Hold, 0 Sell — consensus Hold.
Did ZVRA beat earnings?
ZVRA last reported on Nov 3, 2026: EPS $0.18 vs $0.16 expected — a beat of 14.2%.
What is ZVRA's P/E ratio?
ZVRA trades at a P/E of 9.8 vs a Healthcare average of 17.7.
Does ZVRA pay a dividend?
ZVRA does not currently pay a dividend.
What are ZVRA support and resistance levels?
Support: $10.55, $9.95, $9.10. Resistance: $11.46, $12.20, $12.90.
What are insiders doing with ZVRA?
Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.
What is the latest news on ZVRA?
Nov 3, 2026: Zevra Therapeutics holds Q3 2026 earnings call · Nov 3, 2026: Zevra Therapeutics quarterly profit and revenue top Wall Street targets · Nov 3, 2026: Zevra Therapeutics Posts Q3 2026 Financials